| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 881,500 | 1,034,700 | 1,027,600 | 1,216,600 | | Cost of Revenue | 679,900 | 798,000 | 822,500 | 974,400 | | | Gross Profit | 201,600 | 236,700 | 205,100 | 242,200 | | | Operating Expenses | | Research Development | (287,300) | 153,300 | 134,000 | 137,800 | | Selling General and Administrative | 423,500 |
-
|
-
|
-
| | Non Recurring | 9,300 | 23,500 | 705,900 | 26,900 | | Others | 8,500 | 8,400 | 8,300 | 6,100 | | | | Total Operating Expenses | 154,000 |
-
|
-
|
-
| | | | Operating Income or Loss | 47,600 | 51,500 | (643,100) | 71,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,300 | 2,100 | 2,000 | (193,400) | | Earnings Before Interest And Taxes | 18,000 | 53,600 | (641,100) | (122,000) | | Interest Expense | 29,200 | 52,300 | 48,900 | 32,500 | | Income Before Tax | (11,200) | 1,300 | (690,000) | (154,500) | | Income Tax Expense | 3,600 | (6,200) | (61,000) | (54,400) | | Minority Interest |
-
|
-
|
-
| 1,000 | | | | Net Income From Continuing Ops | (14,800) | 7,500 | (629,000) | (99,100) | | | Non-recurring Events | | Discontinued Operations | (640,600) | (26,300) | (28,300) | (122,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,900) | (18,800) | (657,300) | (221,100) | | Preferred Stock And Other Adjustments | (1,700) | 700 | 1,000 |
-
| | | Net Income Applicable To Common Shares | ($17,600) | ($18,100) | ($656,300) | ($221,100) |
|
0.01% Nasdaq 
Income Statement
